Athena Security
Athena Security uses advanced concealed weapons detection systems to deliver a unified, AI-driven entryway solution for hospitals, K–12 schools, casinos, places of worship, government buildings, and commercial facilities across the U.S. The Apollo 500 enables seamless walk-through screening to detect weapons in real time, giving operators more actionable data points than traditional systems for faster, more confident decisions. Athena’s AI-powered X-ray leverages iPad technology to modernize screening and improve threat detection.
Athena’s Hospital Visitor Management System integrates with EPIC to connect identity, access, and screening data. Innovations include the Ambulance Bay WDS for stretcher screening and secondary screening for bags and lower extremities to reduce human error. Designed with compliance in mind, Athena aligns with California AB 2975, which mandates weapons detection screening at key hospital entrances by 2027 to improve safety and reduce workplace violence.
DHS-aligned workflows ensure testing, controls, and compliance, while telepresence and AR alert glasses provide real-time support. All systems connect in one platform for centralized monitoring and enterprise reporting.
Learn more
Elation Health
Elation Health is the leading platform for primary care, empowering 32,000 clinicians to deliver personalized care to over 16 million patients. With a clinical-first EHR, integrated billing, and AI-powered tools, Elation simplifies care workflows to help independent practices thrive.
Learn more
BenevolentAI
BenevolentAI is a pioneering platform that leverages artificial intelligence and scientific technology to enhance drug discovery processes, specifically targeting complex diseases by efficiently processing and interpreting extensive biomedical data to yield actionable insights more swiftly than conventional approaches. By utilizing its unique Benevolent Platform, the company seamlessly integrates both structured and unstructured biomedical information—spanning literature, genomics, clinical data, and multi-omics—into a detailed knowledge graph. This robust framework empowers researchers to analyze biological systems, formulate testable hypotheses, identify new drug targets, and create potential drug candidates with increased confidence and reduced failure rates, ultimately transforming the landscape of medicine development. With its innovative approach, BenevolentAI stands at the forefront of a new era in the pharmaceutical industry.
Learn more
BigOmics Analytics
BigOmics Analytics is an innovative startup focused on biodata analytics, creating platforms that empower biologists to effectively visualize and interpret their omics data. Our primary offering, Omics Playground, is a highly intuitive bioinformatics tool tailored for RNA-seq and proteomics, enabling users to store their experimental data and visualize it interactively. With more than 18 interactive analysis modules and over 150 dynamic plots, the platform supports co-analysis with a vast array of more than 6,000 public datasets, in addition to providing access to more than 50,000 public gene sets and pathways. Furthermore, it seamlessly incorporates drug connectivity and drug sensitivity databases, featuring an extensive collection of over 30,000 drug expression profiles. BigOmics Analytics is designed to promote collaboration between biologists and bioinformaticians, allowing users to uncover insights while minimizing the time spent on data analysis, all without the need for any programming knowledge. The platform's commitment to producing reliable and reproducible results is achieved through the implementation of state-of-the-art methodologies. Ultimately, BigOmics Analytics is revolutionizing the way biological data is analyzed and understood.
Learn more
